NL
RNAM

NWAM LLC’s Avidity Biosciences RNAM Stock Holding History

NWAM LLC’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,824
Closed -$530K – 666
2025
Q3 		$530K Sell
10,824
-2,773
-20% -$112K 0.03% 398
2025
Q2 		$499K Sell
13,597
-1,809
-12% -$53.9K 0.03% 395
2025
Q1 		$455K Buy
15,406
+309
+2% +$9.62K 0.04% 333
2024
Q4 		$439K Sell
15,097
-14,565
-49% -$609K 0.03% 401
2024
Q3 		$1.36M Buy
29,662
+5,746
+24% +$249K 0.08% 218
2024
Q2 		$977K Sell
23,916
-3,446
-13% -$98.9K 0.29% 56
2024
Q1 		$695K Sell
27,362
-1,959
-7% -$30.7K 0.06% 274
2023
Q4 		$265K Sell
29,321
-6,372
-18% -$42.6K 0.02% 465
2023
Q3 		$228K Buy
35,693
+4,928
+16% +$42.5K 0.02% 448
2023
Q2 		$341K Buy
30,765
+9,265
+43% +$116K 0.03% 389
2023
Q1 		$330K Buy
21,500
+3,759
+21% +$82.7K 0.03% 345
2022
Q4 		$394K Sell
17,741
-2,000
-10% -$29.8K 0.03% 356
2022
Q3 		$322K Hold
19,741
– – 0.03% 372
2022
Q2 		$337K Hold
19,741
– – 0.03% 386
2022
Q1 		$365K Buy
19,741
+1,087
+6% +$18.5K 0.03% 379
2021
Q4 		$443K Sell
18,654
-2,100
-10% -$50.2K 0.04% 351
2021
Q3 		$511K Sell
20,754
-1,900
-8% -$41.3K 0.05% 320
2021
Q2 		$560K Sell
22,654
-9,267
-29% -$216K 0.05% 291
2021
Q1 		$696K Buy
+31,921
New +$781K 0.07% 255

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NWAM LLC's RNAM Position: Q4 2025 in Review

NWAM LLC sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 10,824 shares — an estimated $530K sold.

NWAM LLC first reported a position in RNAM in Q1 2021 and held it in 19 quarters. The position peaked at $1.36M in Q3 2024. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • NWAM LLC reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • NWAM LLC sold 10,824 Avidity Biosciences shares in Q4 2025, an estimated $530K.
  • NWAM LLC first reported a position in Avidity Biosciences in Q1 2021 and held it in 19 quarters.
  • NWAM LLC's Avidity Biosciences position peaked at $1.36M in Q3 2024.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on NWAM LLC's 13F filing for Q4 2025, filed 4 Feb 2026.